X-Chem is a leading small molecule drug discovery company based in Waltham, MA. They are pioneers in the field of DNA-encoded library (DEL) technology and combine their expertise in DEL and medicinal chemistry with groundbreaking AI solutions to accelerate the drug discovery process. With their proprietary ArtemisAI platform, X-Chem revolutionizes the discovery of new medicines by leveraging machine learning models and extensive DEL data to unlock the full potential of rich datasets.
Collaborating with top pharmaceutical companies, X-Chem has a proven track record of success in developing high-potential drug candidates. Their innovative approach to DEL libraries and screening has the potential to overcome challenges in drugging difficult oncology targets and other therapeutic areas. With cutting-edge technology and a commitment to creating breakthrough pharmaceuticals, X-Chem is at the forefront of accelerating small molecule drug discovery.
Generated from the website